Taurodeoxychloic acid

CAS: 516-50-7

Ref. 3D-FT138668

Produktinformation

• Name: Taurodeoxychloic acid
• Synonyme: 2-[[(3α,5β,12α)-3,12-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic acid, 3α,12α-Dihydroxy-5β-cholanic acid-24-taurine, Cholane, ethanesulfonic acid deriv., Deoxycholyltaurine, Deoxytaurocholic acid, Ethanesulfonic acid, 2-(((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)amino)-, Ethanesulfonic acid, 2-[[(3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-yl]amino]-, N-(3a,12a-dihydroxy-5b-cholan-24-oyl)-Taurine, Taurine, N-(3α,12α-dihydroxy-5β-cholan-24-oyl)-, Taurodeoxycholic acid, Taurodesoxycholic acid, Tudcabil

Beschreibung

Taurodeoxycholic acid (TDCA) is a bile acid that is synthesized from cholesterol in the liver. TDCA is conjugated with glycine to form taurodeoxycholate, which is then secreted into the bile and aids in digestion. TDCA has been shown to induce apoptosis by activating the death receptor pathway and inhibiting protein synthesis. It also inhibits inflammation by suppressing the production of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6. Taurodeoxycholic acid has been shown to be useful in treating injury due to its ability to reduce dextran sulfate binding to tissue proteins, preventing tissue injury and cell death.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 499.7 g/mol
• Formel: C₂₆H₄₅NO₆S
• Reinheit: Min. 95%